AIM ImmunoTech adopts Cash Conservation Plan; independent directors paid entirely in stock

AIM ImmunoTech Inc.

Independent directors will receive 100% of board compensation in shares, effective immediately; no cash compensation.
Twice-monthly stock grants valued at closing price on last trading day before grant.
Previously announced CEO Thomas Equels and COO Peter Rodino agreed to reduce cash salaries by $200k and $50k, effective Sept 11, 2024.
Company encourages shareholders to vote for incumbent directors at Dec 17, 2024 annual meeting on WHITE proxy card.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.